Compare OCFC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | OCFC | RAPP |
|---|---|---|
| Founded | 1902 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 1996 | 2024 |
| Metric | OCFC | RAPP |
|---|---|---|
| Price | $19.22 | $28.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $21.33 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 778.7K | 331.7K |
| Earning Date | 01-22-2026 | 03-10-2026 |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.17 | N/A |
| Revenue | ★ $388,753,000.00 | N/A |
| Revenue This Year | $46.71 | N/A |
| Revenue Next Year | $21.25 | N/A |
| P/E Ratio | $16.74 | ★ N/A |
| Revenue Growth | ★ 3.60 | N/A |
| 52 Week Low | $14.29 | $6.43 |
| 52 Week High | $20.61 | $42.27 |
| Indicator | OCFC | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 55.51 | 56.49 |
| Support Level | $18.15 | $25.78 |
| Resistance Level | $20.02 | $27.60 |
| Average True Range (ATR) | 0.58 | 1.69 |
| MACD | 0.12 | 0.20 |
| Stochastic Oscillator | 60.90 | 97.62 |
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.